|
DERL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.64640000311201E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.71890000513864E-08 |
| Normal-vs-Stage2 |
3.637700E-02 |
| Normal-vs-Stage3 |
3.517300E-03 |
| Normal-vs-Stage4 |
4.562200E-03 |
| Stage1-vs-Stage2 |
5.065800E-01 |
| Stage1-vs-Stage3 |
4.666300E-02 |
| Stage1-vs-Stage4 |
2.901000E-01 |
| Stage2-vs-Stage3 |
6.256000E-01 |
| Stage2-vs-Stage4 |
9.007400E-01 |
| Stage3-vs-Stage4 |
6.217000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.35930000167673E-08 |
| Normal-vs-AfricanAmerican |
2.065000E-03 |
| Normal-vs-Asian |
4.011000E-04 |
| Caucasian-vs-AfricanAmerican |
3.767800E-01 |
| Caucasian-vs-Asian |
7.594200E-01 |
| AfricanAmerican-vs-Asian |
5.343200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.779130E-03 |
| Normal-vs-Female |
2.41709999793116E-08 |
| Male-vs-Female |
1.930410E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.61950000077127E-08 |
| Normal-vs-Age(41-60Yrs) |
1.99529000000087E-05 |
| Normal-vs-Age(61-80Yrs) |
9.952300E-02 |
| Normal-vs-Age(81-100Yrs) |
3.899800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.505900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.565300E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.848800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.976100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.498600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.916200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.110600E-01 |
| Classical-VS-Follicular |
3.248300E-04 |
| Classical-VS-Other |
2.674200E-01 |
| Classical-VS-Normal |
1.09430020600598E-10 |
| Tall-VS-Follicular |
4.620000E-02 |
| Tall-VS-Other |
6.169800E-01 |
| Tall-VS-Normal |
1.919390E-03 |
| Follicular-VS-Other |
8.232000E-01 |
| Follicular-VS-Normal |
4.212000E-01 |
| Other-VS-Normal |
6.741800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.754600E-04 |
| Normal-vs-N1 |
3.827800E-02 |
| N0-vs-N1 |
7.943400E-01 |
|
|
